close
  • Company
  • News
  • Products
  • Join us
  • Media
Contact
  • Français
  • English
  • Deutsch
  • Español
  • Italiano
  • Nederlands
  • atom/logo/default Created with Sketch.
    • Company
    • News
    • Products
    • Join us
    • Media
    Contact
    en
    • fr
    • en
    • de
    • es
    • it
    • nl
    close

    Legal notice

    This Site is published by Diabeloop SA, a French société anonyme with a share capital of € 1,006,095, registered with the trade and companies registry under the number RCS 810 416 438 Grenoble, whose registered office is located 155-157, Cours Berriat, 38000 Grenoble Cedex 1, France. Diabeloop may be reached by e-mail at info@diabeloop.com or by phone at +33 (0)04 76 09 54 18.

    The Publishing Director of this Site is Erik Huneker.

    This website is hosted by exclusively by data centers located in Europe (Germany and the Republic of Ireland) by Amazon Web Services (AWS).

    Host server:

    Amazon Web Services LLC

    Host server address:

    P.O. Box 81226
    Seattle, WA 98108-1226
    http://aws.amazon.com

    These legal notice was last updated on February 2021.

    atom/logo/default Created with Sketch.
    HQ 155-157 cours Berriat
    38028 Grenoble - France
    Diabeloop SA
    • Join us
    • Contact
    • Support
    • Privacy policy
    • Terms and conditions of use
    • Legal notice
    • Cookies
    Twitter Facebook Instagram Created with Sketch. Linkedin

    DBLG1 is a class IIb medical device for the treatment of Type 1 Diabetes in adults 22 years and older.
    Those devices are intended for single patient use and require a prescription.
    YourLoops is a class I medical device intended to be used by people with type 1 diabetes to assist in accessing and reviewing their diabetes data. Legal manufacturer of DBLG1/Yourloops devices is Diabeloop SA.
    For full indications for use and safety information see user manual. All content and information provided by this website is intended as informative and can not serve as a substitute for a health professional’s advice, diagnosis or prescription. All decisions related to your therapy and treatment should be discussed with your doctor.
    DBLG1 has received CE marking but is not available for sale in the United States.
    All content and information provided by this website is intended as informative and can not serve as a substitute for a health professional’s advice, diagnosis or prescription. All decisions related to your therapy and treatment should be discussed with your doctor.
    © 2021 Diabeloop SA. No part of this website may be reproduced in any form whatsoever without the prior permission of Diabeloop. This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any valid legal process, regulation, registration or usage in the country of your origin. Diabeloop & DBLG1 are either registered trademarks or trademarks of Diabeloop in the US and other countries. Dexcom and Dexcom G6, are registered trademarks of Dexcom, Inc. in the United States and/or other countries. The Bluetooth® word mark and logos are registered trademarks owned by Bluetooth SIG, Inc. and any use of such marks by Diabeloop is under license. Last update: November 2020

    Diabeloop uses cookies to offer you a quality user experience and to measure the audience. By continuing your visit to this site, you accept the use of cookies under the conditions provided by our privacy policy.OkRefuse cookies
    You may revoke your consent at any time by using the "Revoke Consent" button.Revoke cookies